Acadia Healthcare (NASDAQ: ACHC), known for its comprehensive behavioral health services, recently announced its acquisition of three opioid treatment clinics in South Carolina. These facilities, now rebranded under Acadia’s Comprehensive Treatment Center (CTC) service line, mark the company’s first entry into the state’s opioid treatment market. With South Carolina’s unmet need for addiction services, this acquisition represents a significant step in expanding access to medication-assisted treatment (MAT) for individuals battling opioid use disorder.
Acadia Healthcare’s Commitment to Expanding Treatment Access
As the largest stand-alone provider of behavioral health services in the United States, Acadia Healthcare operates 258 facilities nationwide. With over 23,500 employees, the organization serves approximately 75,000 patients daily, offering services ranging from inpatient psychiatric care to outpatient addiction treatment. The recent acquisition of these South Carolina clinics reflects the company’s ongoing efforts to provide critical care in regions with limited resources for addiction treatment.
The three clinics, formerly known as Recovery Concepts, Recovery Concepts of the Carolina Upstate, and Clear Skye Treatment Center, have now been rebranded as Clinton Comprehensive Treatment Center, Easley Comprehensive Treatment Center, and Ridgeland Comprehensive Treatment Center, respectively. These facilities will offer a range of services, including medication-assisted treatment (MAT), counseling, and other supportive therapies, to help patients achieve long-term recovery.
Addressing South Carolina’s Opioid Crisis
South Carolina has faced significant challenges related to opioid addiction, with rising rates of opioid use disorder in recent years. The state has seen increased demand for treatment services, making Acadia Healthcare’s expansion into the region especially timely. By offering medication-assisted treatment combined with behavioral health services, Acadia’s CTCs will provide a critical resource for individuals seeking recovery.
The newly acquired clinics have established reputations for delivering positive outcomes through a combination of medical treatment and counseling services. As part of Acadia’s nationwide network, these centers will continue their mission of providing accessible, evidence-based care for individuals struggling with opioid use disorder.
A Broader Strategy for National Expansion
This acquisition follows Acadia Healthcare’s recent move into North Carolina, where the company acquired three CTCs earlier this year. Expanding its presence in the Carolinas is a key part of Acadia’s larger growth strategy, which includes mergers and acquisitions, new facility openings, and partnerships with local healthcare providers. The company’s CTC division now operates 165 locations across 33 states, providing care to over 72,000 patients each day.
NASDAQ: ACHC has emphasized the importance of addressing the opioid epidemic, and the acquisition of these South Carolina facilities aligns with the company’s broader goals of expanding treatment access and improving patient outcomes. The CTCs will continue to provide medication-assisted treatment while integrating a range of supportive services, including individual and group therapy, to address the diverse needs of their patients.
As the opioid crisis continues to impact communities across the U.S., Acadia Healthcare remains focused on providing comprehensive care through its extensive network of treatment centers. By acquiring these South Carolina clinics, the company strengthens its position as a leading provider of addiction treatment services, ensuring that individuals in underserved regions have access to the care they need.
